7-2-2020Next week, members of the HIV community from around the globe will gather virtually for the 23rd International AIDS Conference (AIDS 2020: Virtual) and, once a…
5-15-2020Cross-posted from NIAID NewsroomStudy Enrolling Adults with Mild to Moderate COVID-19 in the United States.Adults interested in participating in the trial shoul…
3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…
3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…
3-9-2020Cross-posted from NIAID NewsroomThe cancer drug paclitaxel and a suppressive regimen of antiretroviral therapy (ART) is an effective treatment for AIDS-related …
3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …
2-25-2020Cross-posted from National Institutes of HealthLess than one in four adolescent men who have sex with men (AMSM) ever get tested for HIV, research funded by the…
2-25-2020Cross-posted from National Institutes of HealthDespite similar rates of enrollment into medical care, youth with HIV have much lower rates of viral suppression …
